Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis

Journal of Cardiology

Volumn 60, Issue 6, 2012, Pages 448-453

  Shafee, Mohamed Abdel ^a   Fukuda, Koji ^a   Wakayama, Yuji ^a   Nakano, Makoto ^a   Kondo, Masateru ^a   Hasebe, Yuhi ^a   Kawana, Akiko ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiomyopathies; Magnetic resonance imaging; Other; Prognosis; Ventricular arrhythmias

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL FEATURE; CONTROLLED STUDY; DIASTOLE; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; IMAGE ENHANCEMENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PROGNOSIS; SARCOIDOSIS; SYSTOLE;

AGED; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; SARCOIDOSIS; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84869086846     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.08.002     Document Type: Article

References (40)

1. Baughman R.P., Teirstein A.S., Judson M.A., Rossman M.D., Yeager H., Bresnitz E.A., DePalo L., Hunninghake G., Iannuzzi M.C., Johns C.J., McLennan G., Moller D.R., Newman L.S., Rabin D.L., Rose C., et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001, 15:1885-1889.
2. Dubrey S.W., Falk R.H. Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis 2010, 52:336-346.
3. Yazaki Y., Isobe M., Hiroe M., Morimoto S., Hiramitsu S., Nakano T., Izumi T., Sekiguchi M. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001, 88:1006-1010. Central Japan Heart Study Group.
4. Roberts W.C., McAllister H.A., Ferrans V.J. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med 1976, 63:86-108.
5. Silverman K.J., Hutchins G.M., Bulkley B.H. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978, 58:1204-1211.
6. Akbar J.J., Meyer C.A., Shipley R.T., Vagal A.S. Cardiopulmonary imaging in sarcoidosis. Clin Chest Med 2008, 29:429-443.
7. Marshman R.S. Prevalence of pulmonary sarcoidosis in the state of Victoria, Australia. Acta Med Scand Suppl 1964, 425:167-168.
8. Winters S.L., Cohen M., Greenberg S., Stein B., Curwin J., Pe E., Gomes J.A. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991, 18:937-943.
9. Sarcoidosis diagnostic criteria revising committee Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Dis 2007, 27:89-102.
10. Miller J.M., Zipes D.P. Diagnosis of cardiac arrhythmias. Heart disease 2011, 798. Saunders Elsevier, Philadelphia. 9th ed. E. Braunwald (Ed.).
11. Ichinose A., Otani H., Oikawa M., Takase K., Saito H., Shimokawa H., Takahashi S. MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. Am J Roentgenol 2008, 191:862-869.
12. Villa-Forte A., Mandell B.F. Rheumatic diseases and the cardiovascular system. Heart disease 2011, 1889. Saunders Elsevier, Philadelphia. 9th ed. E. Braunwald (Ed.).
13. Matsui Y., Iwai K., Tachibana T., Fruie T., Shigematsu N., Izumi T., Homma A.H., Mikami R., Hongo O., Hiraga Y., Yamamoto M. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976, 278:455-469.
14. Cox D.R. Regression models and life-tables. J R Stat Soc (B) 1972, 34:187-220.
15. Habersberger J., Manings V., Taylor A.J. Cardiac sarcoidosis. Intern Med J 2008, 38:270-277.
16. Lewin R.F., Mor R., Spitzer S., Arditti A., Hellman C., Agmon J. Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 1985, 110:116-122.
17. Gibbons W.J., Levy R.D., Nava S., Malcolm I., Marin J.M., Tardif C., Magder S., Lisbona R., Cosio M.G. Subclinical cardiac dysfunction in sarcoidosis. Chest 1991, 100:44-50.
18. Kim J.S., Judson M.A., Donnino R., Gold M., Cooper L.T., Prystowsky E.N., Prystowsky S. Cardiac sarcoidosis. Am Heart J 2009, 157:9-21.
19. Matsumori A., Hara M., Nagai S., Izumi T., Ohashi N., Ono K., Sasayama S. Hypertrophic cardiomyopathy as a manifestation of cardiac sarcoidosis. Jpn Circ J 2000, 64:679-683.
20. Bayes de Luna A., Coumel P., Leclercq J.F. Ambulatory sudden cardiac death mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989, 117:151-159.
21. Valenzuela T.D., Roe D.J., Nichol Clark L.L., Clark L.L., Spaite D.W., Hardman R.G. Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med 2000, 343:1206-1209.
22. Suzuki T., Kanda T., Kubota S., Imai S., Murata K. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest 1994, 106:1021-1024.
23. Abeler V. Sarcoidosis of the cardiac conducting system. Am Heart J 1979, 97:701-707.
24. Honda T., Kanazawa H., Koga H., Miyao Y., Fujimoto K. Heart rate on admission is an independent risk factor for poor cardiac function and in-hospital death after acute myocardial infarction. J Cardiol 2010, 56:197-203.
25. Myerburg R.J. Implantable cardioverter-defibrillators after myocardial infarction. N Engl J Med 2008, 359:2245.
26. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996, 335:1933-1940.
27. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., McNulty S.E., Clapp-Channing N., Davidson-Ray L.D., Fraulo E.S., Fishbein D.P., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352:225-237.
28. Patel M.R., Cawley P.J., Heitner J.F., Klem I., Parker M.A., Jaroudi W.A., Meine T.J., White J.B., Elliott M.D., Kim H.W., Judd R.M., Kim R.J. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009, 120:1969-1977.
29. Vignaux O., Dhote R., Duboc D., Blanche P., Dusser D., Weber S., Legmann P. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis. A 1-year follow-up study. Chest 2002, 122:1895-1901.
30. Bello D., Fieno D.S., Kim R.J., Pereles F.S., Passman R., Song G., Kadish A.H., Goldberger J.J. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 2005, 45:1104-1108.
31. Schmidt A., Azevedo C.F., Cheng A., Gupta S.N., Bluemke D.A., Foo T.K., Gerstenblith G., Weiss R.G., Marbán E., Tomaselli G.F., Lima J.A., Wu K.C. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007, 115:2006-2014.
32. Assomul R.G., Prasad S.K., Lyne J., Smith G., Burman E.D., Khan M., Sheppard M.N., Poole-Wilson P.A., Pennell D.J. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006, 48:1977-1985.
33. Cho J.R., Park S., Choi B.W., Kang S.M., Ha J.W., Chung N., Choe K.O., Cho S.Y., Rim S.J. Delayed enhancement magnetic resonance imaging is a significant prognostic factor in patients with non-ischemic cardiomyopathy. Circ J 2010, 74:476-483.
34. Adabag A.S., Maron B.J., Appelbaum E., Harrigan C.J., Buros J.L., Gibson C.M., Lesser J.R., Hanna C.A., Udelson J.E., Manning W.J., Maron M.S. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008, 51:1369-1374.
35. Nojiri A., Hongo K., Kawai M., Komukai K., Sakuma T., Taniguchi I., Yoshimura M. Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy. J Cardiol 2011, 58:253-260.
36. Iles L., Pfluger H., Lefkovits L., Butler M.J., Kistler P.M., Kaye D.M., Taylor A.J. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol 2011, 57:821-828.
37. Hsia H.H., Callans D.J., Marchlinski F.E. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation 2003, 108:704-710.
38. Mehta D., Mori N., Goldbarg S.H., Lubitz S., Wisnivesky J.P., Teirstein A. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed electrical stimulation. Circ Arrhythm Electrophysiol 2011, 4:43-48.
39. Aoki T., Fukumoto Y., Sugimura K., Oikawa M., Satoh K., Nakano M., Nakayama M., Shimokawa H. Prognostic impact of myocardial interstitial fibrosis in non-ischemic heart failure: comparison between preserved and reduced ejection fraction heart failure. Circ J 2011, 75:2605-2613.
40. Cheong B.Y.C., Muthupillai R., Wilson J.M., Sung A., Huber S., Amin S., Elayda M.A., Lee V.V., Flamm S.D. Prognostic significance of delayed-enhancement magnetic resonance imaging. Circulation 2009, 120:2069-2076.